STOCK//SHORTER / BACKTEST ARCHIVE / CRM

Short CRM (Salesforce)

Historical reconstruction: This record was not published on January 17, 2025. It is research-only backtest content for manual review, not investment advice or a trade recommendation.
Conviction72/100
Debt/Cash Fragility34/100
Evidence Depth58/100
Forward Downside58/100

Core Thesis

Reconstructed as-of thesis: CRM was a high-multiple seat-based software incumbent facing AI-agent pressure on workflow automation, sales operations headcount, and renewal seat expansion.

AI Disruption Vector

AI agents reduce the need for manual CRM data entry, sales admin workflows, service routing, and expensive add-on seats.

Revenue Compression Mechanism

Seat compression, lower attach rates, budget scrutiny, and customer consolidation toward AI-native workflow layers.

Failure Horizon

18-36 months for multiple compression; insolvency risk is low absent a severe acquisition/debt shock.

Debt And Cash-Flow Runway

Net debt posture: Large-cap software profile with meaningful liquidity; bankruptcy is not the core thesis.

Cash-flow pressure: Primary risk is growth deceleration and margin defense rather than immediate cash burn.

Downturn runway: Longer than 24 months in normal stress; monitor acquisition debt, buybacks, and subscription growth quality.

Bankruptcy risk window: Not a near-term bankruptcy candidate without extraordinary revenue shock.

Lower financial fragility reduces pure short urgency; thesis needs valuation, AI-seat compression, and catalyst timing to carry conviction.

Strategy Backtest Scenarios

  • Short equity research scenario: Tracks whether multiple compression and renewal weakness would have produced broad downside. Strategy research score: 55/100. Capital efficiency: 58/100. Drawdown risk: 87/100. Upside capture: High if AI narrative shifts from growth enabler to seat cannibalization. Principal risks: Large platform durability, buybacks, earnings beats, and AI product bundling can squeeze shorts.
  • Long put research scenario: Tests defined-risk exposure around earnings or major product cycle resets. Strategy research score: 65/100. Capital efficiency: 88/100. Drawdown risk: 32/100. Upside capture: Convex payoff if downside catalyst arrives inside the option window. Principal risks: Theta decay, implied-volatility crush, and mistimed catalysts.

Backtest Outcome Gate

Window: 12 months from as-of date

Do not present realized return until historical prices and corporate actions are verified.

As-of price: $324.00. User-supplied as-of price placeholder; requires market-data provider verification before performance claims.

Supported realized-return calculators: Short equity, Long put, Long put spread, Bear call spread, Short call.

Evidence Queue

Compliance

Historical reconstruction/backtest; not published on the as-of date. Research only, not investment advice, not a recommendation to buy or sell any security, and not a personalized trading strategy.

Get the live desk version.

Archive records are reconstructed. Live Daily Short research and alert digests are reviewed separately before distribution.